Subsequent experiments deduced that circ-EPB41L5 was significantly downregulated in glioblastoma tissues and associated with several clinical features, including age, number of lesions, necrosis change, recurrence, survival, and prognosis of glioblastoma patients. Here, EPB41L5 is linked to glioblastoma.